The iPLEDGE program is a risk evaluation and mitigation strategy (REMS). The Food and Drug Administration (FDA) may require a REMS to help ensure that a medication’s benefits outweigh its risks. A ...
After years of debate and disagreement, could an improved, more user-friendly version of iPLEDGE be on the horizon? iPLEDGE, the US Food and Drug Administration (FDA)-required Risk Evaluation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results